BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 10, 2006
View Archived Issues
Merck Buying GlycoFi For $400M, Abmaxis For $80M
Merck & Co. Inc. set in motion two definitive agreements to acquire privately held biotechnology companies GlycoFi Inc. and Abmaxis Inc., and $400 million for $80 million, respectively, and would pay cash for both. (BioWorld Today)
Read More
Avidia's Third Round: $44M For Avimer-Based Pipeline
Read More
Avicena Drug Misses Endpoint But Shows Improved Mortality
Read More
Pharmasset Files For $75M IPO; Caprion Bids To Go Public, Too
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Appointments And Advancements
Read More